Tumor two harbored a mutation in PIK3C2A, encoding the class II PI3K-C2α enzymes; the role of this enzyme in cell signaling and cell survival has been debated [36], but the most recent evidence indicates that it does not activate AKT [37]. This evidence concerns the gene AKT1 and neoplasm.